SCHEMBL7009383

SCHEMBL7009383

O=C(COc1ccccc1S(=O)(=O)Cl)Nc1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.64
▸ RAB9A P51151 6/20 0.64
▸ TP53 P04637 3/20 0.64
▸ PKM P14618 2/20 0.64
▸ HPGD P15428 2/20 0.59
▸ MITF O75030 1/20 0.59
▸ XBP1 P17861 1/20 0.59
▸ GAA P10253 1/20 0.54
▸ ALDH1A1 P00352 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ NOTUM Q6P988 1/20 0.48
▸ MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009381 0.81 KMT2A (0.62) NPC1RAB9ATP53PKMHPGD
SCHEMBL9722697 0.78 NPC1 (0.67) NPC1RAB9ATP53PKMHPGD
SCHEMBL9722680 0.76 RAB9A (0.77) NPC1RAB9ATP53PKMHPGD
SCHEMBL6646837 0.76 NPC1 (0.52) NPC1RAB9ATP53HPGDALDH1A1
SCHEMBL27374898 0.74 NPC1 (1.00) NPC1RAB9ATP53PKMHPGD
SCHEMBL10767035 0.74 L3MBTL1 (0.54) HPGDALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL14721936 0.74 LMNA (0.47) HPGDGAAALDH1A1KMT2AKDM4E
Hydrochloric Acid SCHEMBL7014888 0.74 GAA (0.69) NPC1RAB9ATP53PKMHPGD
SCHEMBL969459 0.73 NPC1 (0.71) NPC1RAB9ATP53PKMHPGD
SCHEMBL9722714 0.73 RAB9A (0.64) NPC1RAB9ATP53PKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6559167-B1 Prodrugs of the pyridyl methyl sulfinyl benzimidazole type proton pump inhibitor drugs have a hydrolyzable arylsulfonyl or heteroarylsulfonyl group attached to the benzimidazole nitrogen. The prodrugs of the invention hydrolyze under REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-06 — — US disclosed
EP-1105387-B1 PRODRUGS OF PROTON PUMP INHIBITORS WINSTON PHARMATEUTICALS LLC (US) 2003-01-29 — — EP disclosed
EP-1105387-A1 PRODRUGS OF PROTON PUMP INHIBITORS Partnership of Michael E. Garst, George Sachs and Jai Moo Shin (US) 2001-06-13 — — EP disclosed
WO-2000009498-A1 PRODRUGS OF PROTON PUMP INHIBITORS PARTNERSHIP OF MICHAEL E. GARST, GEORGE SACHS AND JAI MOO SHIN (US) 2000-02-24 — — WO disclosed
Send feedback